Clinical Application Advances And Precision Medicine Practice

Clinical Application Advances and Precision Medicine Practice

The role of puncture needles in clinical medicine is undergoing a profound transformation-evolving from traditional diagnostic sampling tools into indispensable core instruments for executing precision medicine. Clinical practice evidence from 2025 demonstrates that through cross-disciplinary integration and innovative applications, puncture technology has significantly improved the accuracy of early disease diagnosis and the safety of minimally invasive treatments across multiple fields.

Precision Diagnosis in Prostate Cancer

Research conducted by the Urology Department team at Peking University First Hospital holds milestone significance. Through a rigorously designed randomized controlled trial (RCT), the team confirmed that for patients with suspected prostate cancer presenting a single unilateral suspicious lesion on Magnetic Resonance Imaging (MRI), optimizing the conventional 12-core systematic biopsy scheme down to 6 cores-while simultaneously performing targeted biopsies-does not compromise diagnostic efficacy. The study enrolled 506 eligible patients, comparing the novel "targeted biopsy plus 6-core systematic biopsy" scheme against the traditional "targeted biopsy plus 12-core systematic biopsy" approach. Results indicated that the rates of detecting clinically significant prostate cancer were nearly identical between the two groups (54.3% vs. 54.8%, respectively). Crucially, the optimized scheme not only shortened procedural time and reduced patient pain and discomfort but also lowered the risk of postoperative complications and decreased overall examination costs.

Breakthrough in Splenic Lesion Diagnosis

Addressing the traditionally high-risk area of splenic lesion diagnosis, a research team from the First Affiliated Hospital of Zhejiang University School of Medicine developed a novel biopsy needle integrated with radiofrequency ablation (RFA) functionality, achieving a breakthrough. Given the spleen's rich vascularity and fragile parenchyma, traditional biopsy carries a high risk of hemorrhage (reported bleeding rates range from 2% to 5% or even higher). The innovation of the novel biopsy needle lies in its ability to immediately perform instant, effective thermal coagulation hemostasis on the puncture tract (needle track) after obtaining the tissue sample. This process effectively seals the path from the source, significantly mitigating the potential risks of postoperative bleeding and tumor cell seeding along the needle track. Animal model experiments have preliminarily verified the technical feasibility, safety profile, and efficacy of this technique in reducing bleeding-related complications.

Advancements in Cardiovascular Intervention

At the European Society of Cardiology Congress 2025 (ESC 2025), the Arrhythmia Center team from the First Affiliated Hospital of Ningbo University presented a novel radiofrequency ablation transseptal puncture system, representing a significant advancement in cardiac interventional technology. While transseptal puncture is a critical step for left atrial interventions, traditional mechanical puncture methods face limitations such as technical complexity and a steep learning curve. The new system features an integrated design combining the puncture needle, guidewire, and RF energy generator, greatly enhancing the visibility of the sheath, needle, and wire under intracardiac ultrasound real-time imaging. This improvement ensures high puncture success rates while significantly shortening overall puncture time, all without increasing the risk of serious adverse events or device-related complications.

Innovations in Orthopedics

In the field of orthopedics, the application of trocar (cannulated) puncture technology in percutaneous pedicle screw placement offers safer solutions for patients with osteoporosis or bone destruction. Research from Guangzhou Integrated Traditional Chinese and Western Medicine Hospital indicates that when using this technique, if the needle tip slips upon encountering an area of bone destruction, the inner stylet can be withdrawn first. This allows the cylindrical end of the outer cannula to form stable contact with the bone surface. Under X-ray fluoroscopy, once the puncture direction is confirmed to be accurate, the stylet is reinserted to complete the final puncture. This strategy effectively reduces repeated attempts in difficult percutaneous pedicle puncture cases, thereby lowering associated iatrogenic risks.

Interventional Tumor Diagnosis and Treatment

The fusion of puncture needles with advanced imaging technology has reached new heights in tumor interventional therapy. A team from the Shanghai Public Health Clinical Center employed a robot-guided percutaneous biopsy for a lung ground-glass nodule. By utilizing preoperative 3D imaging for precise planning, they selected a vascular-scarce region as the entry point and adopted a parallel trajectory relative to adjacent blood vessels. Coupled with cryobiopsy technology, they successfully obtained sufficient ideal specimens. Faced with an extremely small (11×9 mm) lesion located adjacent to the pleura, the team innovatively adopted a "long-distance, wide-angle" needle insertion strategy-bypassing closer routes to avoid repeated pleural punctures. By leveraging the robotic system's precise control over the puncture angle and respiratory phases, they ultimately acquired high-quality solid tissue cores.

Conclusion

The common core characteristic of these clinical advancements is an unwavering focus on patient safety and benefit. While ensuring therapeutic efficacy, these innovations maximize the reduction of surgical trauma, lower operational risks, and enhance diagnostic efficiency. Modern puncture needles are no longer simple tools for obtaining biological samples; they have evolved into key instruments for precise localization, accurate diagnosis, and minimally invasive treatment-serving as vital carriers for the practical implementation of precision medicine.